| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 60,206 | 145,612 | ||
| Short-term investments | 99,725 | 49,070 | ||
| Prepaid expenses and other current assets | 4,630 | 3,725 | ||
| Total current assets | 164,561 | 198,407 | ||
| Property and equipment, net | 2,063 | 2,374 | ||
| Finance lease right-of-use assets | 15,931 | 16,689 | ||
| Operating lease right-of-use assets | 3,597 | 4,528 | ||
| Other assets | 3,607 | 2,502 | ||
| Total assets | 189,759 | 224,500 | ||
| Accounts payable | 8,267 | 7,193 | ||
| Accrued and other current liabilities | 16,246 | 13,933 | ||
| Finance lease liabilities, current portion | 17,596 | 16,428 | ||
| Operating lease liabilities, current portion | 3,626 | 3,986 | ||
| Total current liabilities | 45,735 | 41,540 | ||
| Finance lease liabilities, net of current portion | 4,558 | 3,899 | ||
| Operating lease liabilities, net of current portion | 0 | 580 | ||
| Total liabilities | 50,293 | 46,019 | ||
| Voting and non-voting common stock, 0.00001 par value 300,000,000 (293,590,481 voting and 6,409,519 non-voting) shares authorized as of september 30, 2025 and 150,000,000 (143,590,481 voting and 6,409,519 non-voting) shares authorized as of december 31, 2024 96,265,204 voting shares issued and outstanding as of september 30, 2025 and 50,743,101 voting shares issued and outstanding as of december 31, 2024 | 1 | 1 | ||
| Additional paid-in capital | 614,480 | 608,651 | ||
| Accumulated other comprehensive income | 23 | 1 | ||
| Accumulated deficit | -475,038 | -430,172 | ||
| Total stockholders equity | 139,466 | 178,481 | ||
| Total liabilities and stockholders equity | 189,759 | 224,500 | ||
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)